An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants
Clinical trial NCT02535026 · COMPLETED
Trial details
- NCT number
- NCT02535026
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-12-01
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.